Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Curie
AddedFeb 16, 2024
UpdatedJun 18, 2026
Curie

Curie

Curie Co: Engineering enzymes and marine biomaterials to replace harmful chemicals in life sciences.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Curie Co, founded to revolutionize the personal care industry, focuses on engineering enzymes and marine biomaterials to replace harmful and banned chemicals. The company's core mission is to provide sustainable, long-lasting solutions by leveraging biological innovations. Curie Co's offerings include bio-based alternatives to traditional petrochemical ingredients, aimed at enhancing the performance and sustainability of personal care products. Their market focus is on life sciences and personal care formulators seeking eco-friendly and effective solutions.

Notable affiliated individuals and investors include experts in biotechnology and sustainable chemistry, although specific names are not provided. Key achievements for Curie Co include setting new standards for sustainable personal care products and gaining recognition for their innovative use of marine biomaterials. The overall impact of Curie Co has been significant in promoting eco-friendly practices within the personal care industry, providing a viable alternative to harmful chemicals, and advancing the field of life sciences through their biological solutions.

Curie - Similar Companies

Curie.Bio logo

Curie.Bio

curie.bio

Curie London logo

Curie London

Curi Bio logo

Curi Bio

curibio.com

P2 Science logo

P2 Science

p2science.com

Capra Biosciences logo

Capra Biosciences

Cascade Biocatalysts logo

Cascade Biocatalysts

Cypris Materials logo

Cypris Materials

Bucha Bio logo

Bucha Bio

rheom.com

Capro-X logo

Capro-X

capro-x.com

CinderBio logo

CinderBio

cinderbio.com

Cellibre logo

Cellibre

cellibre.com

Ecovia Renewables logo

Ecovia Renewables

Cell-Free Bioinnovations logo

Cell-Free Bioinnovations

cfb9.com

Uncaged Innovations logo

Uncaged Innovations

Solugen logo

Solugen

solugen.com

Curie - Quick Facts

Who are Curie's competitors?

Companies similar to Curie include Curie.Bio, Curie London, Curi Bio and P2 Science.

When was Curie founded?

Curie was founded in 2017.

Where is Curie's headquarters located?

Curie's headquarters is located in New York City, NY, US.

When was Curie's last funding round?

Curie's most recent funding round was for $1.2M (USD) in August 2020.

How much has Curie raised to-date?

As of Aug 24, 2020, Curie has raised a total of $1.4M (USD).

How many employees does Curie have?

Curie has 11 employees as of Feb 4, 2024.

Curie - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Biomaterials
  • Enzymes
Tags
  • Cleantech
  • Ingredients
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified